In the intricate ecosystem of modern healthcare, the battle against infections stands as a cornerstone of patient safety. With patients being vulnerable to infections due to underlying health conditions, invasive procedures, and prolonged hospital stays, the rising tide of antimicrobial resistance (AMR) has further compounded this challenge, emphasising the indispensable role of antimicrobial solutions in infection control.
The Challenge of Infection Control in Hospitals
Healthcare-associated infections (HAIs) remain a significant concern globally. According to the World Health Organization (WHO), an estimated 7% of hospitalised patients in high-income countries and 10% in low- and middle-income countries acquire at least one HAI. These infections can lead to extended hospital stays, increased medical costs, and higher mortality rates.
Common HAIs include bloodstream infections, surgical site infections, pneumonia, and urinary tract infections. These infections often stem from multidrug-resistant organisms (MDROs), such as Methicillin-resistant Staphylococcus aureus (MRSA), Carbapenem-resistant Enterobacteriaceae (CRE), and multidrug-resistant Acinetobacter.
Key Drivers of HAIs:
- Invasive Procedures: devices like catheters, ventilators, and surgical instruments, though essential, provide pathways for pathogens.
- Antimicrobial Resistance: misuse and overuse of antibiotics have fostered the evolution of resistant pathogens, rendering traditional treatments ineffective.
- Environmental Contamination: surfaces, medical equipment, and even healthcare workers’ hands can harbour pathogens, contributing to transmission.
The Role of Antimicrobial Solutions
Antimicrobial solutions encompass a broad range of interventions designed to inhibit or kill microorganisms. They play a pivotal role in reducing the burden of HAIs and enhancing patient outcomes, including Hygenica’s antimicrobial solutions.
With its unique formulation and best-in-class speed of kill, Hygenica’s antimicrobial technology, Fantex®, effectively prevents the transfer of pathogens to interacting hands, helping to break the chain of transmission and significantly reducing the spread of infection within the hospital environment.
Fantex® IPC Curtains:
Surfaces coated with antimicrobial agents can significantly reduce microbial colonisation. Fantex® IPC Curtains kill 99.9% (Log 3) of harmful pathogens in under one minute and remain highly active for the entire hanging time to provide long-lasting protection against cross-contamination.
Currently the only curtain scientifically proven to kill pathogens and remain free from contamination, Fantex® IPC Curtains contribute to a safer patient environment and help to reduce the risk of HCPs or patients contracting life-threatening HCAIs.
Fantex® Duoshield Medical Gowns:
Personal protective equipment (PPE) is one of most used consumable products in hospitals and ensuring they remain safe is critical. The Fantex® Duoshield gown is a high performance gown coated in our best-in-class antimicrobial agent, Fantex®.
On the front-line, patient protection is paramount. Fantex® DuoShield gowns provide a unique antimicrobial shield, effectively breaking the chain of transmission during patient care.
Personal protective equipment (PPE) is one of most used consumable products in hospitals and ensuring they remain safe is critical. The Fantex® Duoshield gown is a high performance gown coated in our best-in-class antimicrobial agent, Fantex®.
On the front-line, patient protection is paramount. Fantex® DuoShield gowns provide a unique antimicrobial shield, effectively breaking the chain of transmission during patient care.
Fantex® Disinfectants:
High-level disinfectants are instrumental in decontaminating hospital environments. Fantex® antimicrobial agents have Log 5 efficacy against a broad spectrum of bacteria, fungi and viruses. With 24-hour residual activity, Fantex® antimicrobial agents provide long-lasting protection for patients.
The Road Ahead
While antimicrobial solutions are invaluable, they must be part of a comprehensive infection control strategy. Education and training for healthcare workers, robust surveillance systems, and a commitment to innovation are essential for sustained progress.
Moreover, addressing the global threat of AMR requires concerted efforts across sectors, including healthcare, agriculture, and public health. Policies supporting research into new antibiotics and alternative therapies, such as bacteriophage treatments and probiotics, are crucial.
Conclusion
The fight against HAIs and AMR is a formidable challenge, but by integrating infection control tools into everyday healthcare practices, such as Fantex®, we can create safer hospital environments, improve patient outcomes, and safeguard the efficacy of life-saving antibiotics for future generations.
References:
- World Health Organization. (2022). Healthcare-associated infections FACT SHEET.
- Centers for Disease Control and Prevention. (2021). Antibiotic Resistance Threats in the United States.
- Rutala, W. A., & Weber, D. J. (2019). Disinfection and sterilization: An overview. American Journal of Infection Control.
